Stock LLY0 ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Eli Lilly and Company Deutsche Boerse AG

Equities

LLY0

CA28655A1066

Market Closed - Deutsche Boerse AG
Other stock markets
 03:59:02 2024-07-15 am EDT 		5-day change 1st Jan Change
22.8 EUR -8.80% Intraday chart for Eli Lilly and Company +2.70% 0.00%
Jul. 12 Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market RE
Jul. 12 Ozempic linked with lower dementia risk, nicotine use, British study finds RE

Chart calendar Eli Lilly and Company

1dc5dc095d6158e9.z4Pd6-tWpaz1M03iFILhe1_K8yxCVIwufLa2xLhl9Xk.m9aumowPwcamYzyPctuMSS6ulmQqO_obSMDwkv8xhQGrtL-p0gLsyrhZOg~c45776e3b7b7d4e29b645ef235486b86

Upcoming events on Eli Lilly and Company

2024-08-08 06:25 am Q2 2024 Earnings Release
2024-08-08 10:00 am Q2 2024 Earnings Call
2024-08-14 Détachement de
2024-10-30 06:25 am Q3 2024 Earnings Release
2024-10-30 10:00 am Q3 2024 Earnings Call
2025-01-29 Q4 2024 Earnings Release (Projected)
2025-04-23 Q1 2025 Earnings Release (Projected)
2025-08-04 Q2 2025 Earnings Release (Projected)
2025-11-03 Q3 2025 Earnings Release (Projected)

Past events on Eli Lilly and Company

2024-06-21 03:45 pm American Diabetes Association Scientific Symposium
2024-06-10 04:00 pm Goldman Sachs Global Healthcare Conference - Fireside Chat
2024-06-03 06:12 pm American Society of Clinical Oncology Meeting - Abstract Number: LBA507
2024-06-03 02:30 pm American Society of Clinical Oncology Meeting - Abstract Number: 8547
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract Number: 5589
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract Number: 11111
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract Number: 11068
2024-06-02 08:30 pm American Society of Clinical Oncology Meeting
2024-06-02 06:06 pm American Society of Clinical Oncology Meeting - Abstract Number: 10022
2024-06-02 10:00 am American Society of Clinical Oncology Meeting - Abstract Number: 1027
2024-06-01 06:00 pm American Society of Clinical Oncology Meeting - Abstract Number: 3007
2024-06-01 04:12 pm American Society of Clinical Oncology Meeting - Abstract Number: 5001
2024-06-01 04:00 pm American Society of Clinical Oncology Meeting - Abstract Number: LBA1001
2024-06-01 02:39 pm American Society of Clinical Oncology Meeting - Abstract Number: 8510
2024-06-01 10:00 am American Society of Clinical Oncology Meeting - Abstract Number: 3150
2024-05-14 Détachement de
2024-05-06 08:30 am Annual General Meeting
2024-04-30 10:00 am Q1 2024 Earnings Call
2024-04-30 06:45 am Q1 2024 Earnings Release
2024-04-08 04:30 pm American Association for Cancer Research Meeting - Abstract Number: 3230

Past dividends on Eli Lilly and Company

2024-05-14 Quarterly 1.3 USD
2024-02-13 Quarterly 1.3 USD
2023-11-13 Quarterly 1.13 USD
2023-08-13 Quarterly 1.13 USD
2023-05-11 Quarterly 1.13 USD
2023-02-13 Quarterly 1.13 USD
2022-11-13 Quarterly 0.98 USD
2022-08-11 Quarterly 0.98 USD
2022-05-12 Quarterly 0.98 USD
2022-02-13 Quarterly 0.98 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		22 320
22 142
0.8%		24 540
24 394
0.6%		28 318
28 205
0.4%		28 541
28 641
-0.35%		34 124
33 585
1.6%
42 982

EBITDA
Million USD		Released
Forecast
Spread 		7 551
7 508
0.57%		8 589
8 676
-1.01%		10 005
9 767
2.43%		9 473
9 494
-0.23%		8 584
8 418
1.98%
16 238

EBIT
Million USD		Released
Forecast
Spread 		6 079
6 106
-0.44%		7 265
7 503
-3.17%		8 457
8 599
-1.65%		7 950
8 164
-2.62%		7 057
6 928
1.86%
14 700

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		5 266
8 975
-41.33%		7 230
7 041
2.68%		6 156
7 148
-13.88%		6 806
7 084
-3.93%		6 555
6 311
3.86%
13 785

Net income
Million USD		Released
Forecast
Spread 		8 318
8 090
2.83%		6 194
5 805
6.69%		5 582
6 019
-7.27%		6 245
6 102
2.35%		5 240
5 307
-1.26%
11 941

EPS
USD		Released
Forecast
Spread 		8,89
8,65
2.83%		6,79
6,36
6.69%		6,12
6,43
-4.75%		6,90
6,60
4.57%		5,80
6,04
-3.92%
13,4

Announcement Date30/01/2029/01/2103/02/2202/02/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		7 810
7 319
6.7%		6 488
6 854
-5.33%		6 942
6 901
0.58%		7 302
7 376
-1%		6 960
6 867
1.36%		8 312
7 590
9.51%		9 499
8 965
5.96%		9 353
8 971
4.27%		8 768
8 930
-1.81%
9 999


11 331


12 799


10 920


12 135

EBITDA
Million USD		Released
Forecast
Spread 		3 046
2 717
12.12%		1 679
2 387
-29.67%		2 373
2 385
-0.5%		2 375
2 268
4.72%		1 982
2 148
-7.73%		2 618
2 416
8.39%		986
3 460
-71.49%		2 855
3 517
-18.81%		3 049
2 827
7.84%
3 749


4 852


5 984







EBIT
Million USD		Released
Forecast
Spread 		2 610
2 336
11.74%		1 330
1 790
-25.7%		2 010
2 007
0.13%		2 000
1 953
2.41%		1 620
1 840
-11.95%		2 252
2 078
8.37%		575
921
-37.56%		2 468
2 448
0.79%		2 648
2 674
-0.96%
3 066


3 979


4 807







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread














2 089
2 107
-0.86%		427
-399
207.07%		2 509
1 248
101.03%		2 536
2 455
3.3%
3 000


3 878


4 497







Net income
Million USD		Released
Forecast
Spread 		1 903
1 711
11.22%		953
1 133
-15.93%		1 452
1 453
-0.09%		1 938
1 681
15.27%		1 345
1 544
-12.9%		1 763
1 660
6.22%		-57,4
-813
92.94%		2 190
1 811
20.89%		2 243
2 058
8.99%
2 461


3 256


4 028







EPS
USD		Released
Forecast
Spread


1,05
1,85
-43.24%		1,61
1,90
-15.26%		2,14
1,78
20.22%		1,49
2,04
-26.96%		1,95
1,81
7.73%		-0,06
-0,66
90.91%		2,42
2,26
7%		2,48
2,44
1.64%
2,76


3,61


4,46







Announcement Date28/04/2204/08/2201/11/2202/02/2327/04/2308/08/2302/11/2306/02/2430/04/24-----

Upcoming sector events for Eli Lilly and Company

2024-07-16 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-17 06:45 am JOHNSON & JOHNSON: Q2 2024 Earnings Release
2024-07-17 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-18 01:00 am NOVARTIS AG: Q2 2024 Earnings Release
2024-07-18 TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release
2024-07-21 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-21 ALMIRALL, S.A.: Q2 2024 Earnings Release
2024-07-22 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-23 INNOVIVA, INC.: Q2 2024 Earnings Release (Projected)
2024-07-23 TILRAY BRANDS, INC.: Q4 2024 Earnings Release (Projected)
More events

Past sector events for Eli Lilly and Company

Today CAMURUS AB: Q2 2024 Earnings Release
2024-07-10 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
2024-07-09 LOTUS PHARMACEUTICAL CO., LTD.: June 2024 Sales and Revenue Release
2024-07-09 07:35 am SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release
2024-07-03 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
2024-07-02 05:05 am ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release
2024-06-21 11:28 am DEVA HOLDING: Q1 2024 Earnings Release
2024-06-13 05:21 pm EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
2024-06-11 01:30 am BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release
2024-06-07 06:33 am SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. LLY Stock
  4. LLY0 Stock
  5. Calendar Eli Lilly and Company